Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. (Q33348914)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. |
scientific article |
Statements
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients (English)
S Greggi
S Pignata
S Tateo
R Biamonte
L Manzione
G Di Vagno
F Ferrau'
G Scambia
Multicenter Italian Trials in Ovarian Cancer invesitgators